Introduction
Platelet aggregation culminates as a result of a complex series of interrelated processes. Intact platelets are activated by the binding of agonists (e.g., thrombin, ADP, and epinephrine) to receptors on the platelet surface. Activation results in the unmasking of specific binding sites for fibrinogen (1) (2) (3) . Although the binding of fibrinogen is known to be essential for aggregation, the mechanism by which fibrinogen binding leads to aggregation is not known.
Several lines of evidence suggest that platelet membrane glycoproteins Ilb and Illa are important in fibrinogen binding to platelets and in platelet aggregation. Platelets from patients with Glanzmann's thrombasthenia which lack these two proteins do not aggregate or bind fibrinogen (4) . In addition, antibody directed against these glycoproteins inhibits fibrinogen binding and platelet aggregation (5) . Finally, a specific photoaffinity derivative of fibrinogen has been shown to bind covalently to glycoprotein lIla (6) .
One approach to the study of platelet aggregation is to reconstitute purified platelet glycoproteins into liposomes. By preselecting proteins to be incorporated into a lipid bilayer one could study the processes necessary for platelet aggregation in a relatively controlled way. In this study we report the successful reconstitution of glycoproteins Ilb and I11a into phospholipid vesicles, and we demonstrate that these proteoliposomes have receptors that mediate binding of the vesicles to activated intact platelets.
(St. Louis, MO) . Phosphatidylcholine was isolated from crude egg phosphatidylcholine by silicic acid chromatography (7) . Antiplatelet monoclonal antibodies were prepared as previously described (8) , and a monoclonal antibody against glycophorin was a gift from Dr Solubilization and reconstitution ofplatelet membrane glycoproteins I1b and IIIa. Platelet membrane glycoproteins Ilb and lIa were obtained in relatively pure form by the procedure described by Newman et al. (9) (Fig. 1) . This method employs a one-step extraction procedure which uses the nonionic detergent Triton X-1 14. To achieve reconstitution, the Triton X-l 14 solubilized material was applied to a DEAE cellulose column at 4VC and eluted with buffer containing 30 mM n-octyl glucoside 10 mM Tris/HCl buffer, pH 7.4. In a standard reconstitution assay, 0.5 ml of the n-octylglucoside protein solution (I mg/ml) was added at room temperature to 1.0 ml of a phosphatidylcholine dispersion. The phosphatidylcholine dispersion was prepared by sonication of phosphatidylcholine (20 mg/ml) in 10 mM Tris/HCI pH 7.4 in an ultrasonic bath sonifier for I h. The clear phosphatidylcholine-protein mixture was dialyzed overnight at 4VC against 10 mM Tris/HCI buffer, pH 7.4, and then passed through a G-50 Sephadex column (I X 18 cm) which had been equilibrated at room temperature with the same buffer. Unincorporated protein was separated from proteoliposomes by passage of the protein-lipid mixture through a Sepharose 4B column (1 X 20 cm) at room temperature. Under these conditions the proteoliposomes were found in the void volume of the column. Reconstitution of the glycoproteins into the liposomes was assayed by passage of vesicles containing '251I-labeled proteins (procedure described below) through the Sepharose 4B column (15 X 0.750 ml) and determination of whether the 1251-glycoproteins cochromatographed with the proteoliposomes (Fig. 2) min at 370C without agitation. Intact platelets with attached radiolabeled proteoliposomes were then separated from unbound vesicles by centrifugation of the mixture through 1.0 ml of an oil containing n-butylphtalate plus corn oil (9/1) for -3 min with a microfuge (Beckman Instruments, Inc., Spinco Div., La Jolla, CA). The top layer containing free vesicles was removed and the pellet containing >80% of the platelets was counted for radioactivity.
Fibrinogen binding to proteoliposomes. '25I-labeled fibrinogen binding to reconstituted vesicles was measured by a method that involved rapid and complete separation of the vesicles from the medium. Proteoliposomes containing 0.5 mg/ml platelet protein were added to a solution (final volume 200 ;d) containing 10-3 M CaCl2, 0.175 M NaCI, 0.02 M Tris/HCI pH 7.4, 2% bovine serum albumin (fraction V; Calbiochem-Behring Corp., San Diego, CA), and 1-3 X 1o' M 1251-fibrinogen. After I h of incubation at 370C 100-,ul aliquots were removed and centrifuged either in an airfuge (Beckman Instruments Inc., Spinco Div.) according to the method of Phillips and Baughan (12) or through a Sepharose 4B column. For the latter method, columns of Sepharose 4B were poured to the l-ml mark in disposable I-ml plastic syringes. The columns were washed with a solution containing 10-3 M CaCl2, 0.175 M NaCl, 2% bovine serum albumin (fraction V; Calbiochem-Behring Corp.), and 0.02 M Tris, pH 7.4. Excluded medium was removed from the columns by centrifugation at 500 g for 3 min in a clinical centrifuge. In a control experiment in which a solution of '25I-labeled fibrinogen without vesicles was applied to the column, <0.1% of the labeled fibrinogen was found in the eluate. Recovery of the vesicles as measured by the amount of protein and phospholipid in the eluate was -90%. (15) .
Results
Orientation of the reconstituted platelet glycoproteins in the proteoliposomes. The functional activity of the reconstituted glycoproteins Ilb and I11a required that the glycoproteins be incorporated into the liposomes with their sialic acid residues exposed on the outer surface of the vesicles (16) . Proteoliposomes were treated with neuraminidase to determine whether the sialic acid residues of the reconstituted glycoproteins were susceptible to hydrolysis. Table I compares the extent of sialic acid release from proteoliposomes and Triton X-100-treated proteoliposomes by V cholera neuraminidase. Approximately 50% of the 3H-labeled sialic acid was removed by neuraminidase after I h of incubation. Longer incubations did not result in further release of sialic acid. Within 60 min after the addition of neuraminidase, -90% of the labeled sialic acid was hydrolyzed from proteoliposomes solubilized with 0.05% Triton X-100. These results demonstrate that 250% of the sialic acid residues of the reconstituted glycoproteins were accessible to neuraminidase. Moreover, the data suggests that the proteins were randomly incorporated into the liposomes with -50% of the glycoproteins oriented such that their sialic acid residues were exposed on the outer surface.
Immunoprecipitation of proteoliposomes with antiplatelet antibodies. Glycoproteins IIb and II1a have been shown to be important for fibrinogen binding to platelets and platelet aggregation (4, 5) . Thus it was important to determine whether these glycoproteins were incorporated into the liposomes in their native orientation before testing whether the proteoliposomes bound fibrinogen. Since Kunicki and Aster (17) have shown that glycoprotein IIla is the carrier of the plA' deter- (18) . As shown in Fig. 4 , anti-PI"A antibody and two antiplatelet monoclonal antibodies immunoprecipitated liposomes reconstituted with '25I-labeled membrane proteins.
A monoclonal antibody raised against glycophorin did not immunoprecipitate these proteoliposomes (Fig. 4, lane E) . Control sera that did not contain either PAI or HLA antigenic activity immunoprecipitated very little labeled protein (Fig. 4,  lane B Liposomes that did not contain platelet proteins showed a marked decrease in binding to thrombin-treated platelets as compared with proteoliposomes, but liposomes did bind to thrombin-treated platelets to a slight degree (Table II, B) . It is unlikely that the different binding properties of proteoliposomes and liposomes was due to differences in the preparation of the vesicles, since those without protein were prepared in exactly the same fashion as those with protein except that during the n-octylglucoside incubation, glycoproteins Ilb and IIIa were not included in the control vesicles.
To test whether the binding of proteoliposomes to thrombintreated platelets was a result of factors normally involved in thrombin mediated platelet aggregation, intact platelets were preincubated with PGI2, a known inhibitor of thrombin induced platelet aggregation (19) , and proteoliposomes were then added. Table III shows that pre-incubation of intact platelets with PGI2 inhibited the binding of proteoliposomes to thrombintreated platelets. However, addition of PGI2 after thrombin addition had little effect. Since PGI2 has been shown to not affect thrombin binding to platelets (1 1), these results suggest that thrombin activation was required for the binding of the proteoliposomes to platelets.
Binding of '251-labeled fibrinogen to proteoliposomes. Fig.   5 shows both the time course of total and nonspecific binding of fibrinogen to reconstituted vesicles and the reversibility of this binding with the subsequent addition of unlabeled fibrin- ogen (10-7 M) . Whereas nonspecific binding reached the maximum after -10 min, specific binding took 60 min for maximum binding (Fig. 5 A) . The addition of about a 50-fold excess of unlabeled fibrinogen displaced -70% of the specific binding (Fig. 5, B platelets. They observed that the binding mimicked plateletaggregation. Our data indicate that liposomes reconstituted with purified platelet proteins will also bind to thrombinactivated platelets. The binding was dependent on factors normally involved in thrombin stimulated platelet aggregation; binding required Ca++ and was inhibited by PGI2.
Proteoliposomes containing glycoproteins lIb and lIla specifically bound fibrinogen. Although binding of fibrinogen to intact platelets requires activation of the fibrinogen binding site with ADP or thrombin (1, 2), fibrinogen binding to proteoliposomes occurred in the absence of ADP or thrombin but required the presence of calcium. Of note, Phillips and Baughan (12) also found that fibrinogen binding to isolated platelet membranes did not require ADP or thrombin. Our data and theirs suggest that fibrinogen receptors become unmasked during isolation of platelet membranes.
The successful reconstitution of platelet proteins into a lipid bilayer now raises the possibility of dissecting the mechanism of platelet aggregation in a physiological environment.
For example, would incorporation of glycoprotein lIla by itself be sufficient for the binding of fibrinogen to proteoliposomes? The reconstitution of platelet function also raises the possibility of clinically useful artificial platelets.
